EPIC-HR: Study of Oral PF-07321332/Ritonavir Compared With Placebo in Nonhospitalized High Risk Adults With COVID-19
Clinical trial NCT04960202 · COMPLETED
Trial details
- NCT number
- NCT04960202
- Sponsor
- Pfizer
- Status
- COMPLETED
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2021-07-16
- Primary completion
- 2021-12-09
- Enrollment
- 2091
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.